Excellent response to asfotase alfa treatment in an adolescent patient with hypophosphatasia
Abstract Hypophosphatasia (HPP) is a rare inherited metabolic disorder characterized by deficient activity of alkaline phosphatase, causing defective mineralization of bones and teeth. The symptoms vary from no symptoms to stillbirth or skeletal manifestations. Since 2015, asfotase alfa, an enzyme r...
Main Authors: | Olivia Sarah Strandbech, Allan Lund, Elsebet Ostergaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12198 |
Similar Items
-
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
by: Orimo H
Published: (2016-05-01) -
Clinical application experience of asfotase alfa for a young patient with childhood hypophosphatasia
by: Nataliya Y. Kalinchenko, et al.
Published: (2019-11-01) -
Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy
by: Bowden SA, et al.
Published: (2018-09-01) -
Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms
by: Yasuko Fujisawa, et al.
Published: (2020-12-01) -
Hearing impairment improved after treatment with asfotase alfa in a case of perinatal hypophosphatasia
by: Rie Chida-Naomiya, et al.
Published: (2020-09-01)